We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New ‘Double Decker’ Antibody-drug Conjugates Fight Cancer

News   Oct 30, 2017 | Original story from The Scripps Research Institute (TSRI)

 
New ‘Double Decker’ Antibody-drug Conjugates Fight Cancer

Left to right: This is an image of study leaders TSRI Professor William R. Roush, Graduate Student Alex Nanna and TSRI Associate Professor Christoph Rader. Credit: The Scripps Research Institute

 
 
 

RELATED ARTICLES

Mouse Study Proposals Promising Parkinson's Molecule

News

A promising molecule has offered hope for a new treatment that could stop or slow Parkinson's. Researchers have found that molecule BT13 has the potential to both boost levels of dopamine, the chemical that is lost in Parkinson's, as well as protect the dopamine-producing brain cells from dying.

READ MORE

Study Links Thyroid Cancer, Genetic Variations and Cell Phones

News

Radiation from cell phones is linked to higher rates of thyroid cancer among people with genetic variations in specific genes, a new study led by the Yale School of Public Health finds.

READ MORE

Novel Drug Targets Advanced Kidney Cancer

News

Scientists have reported promising activity of a novel drug called MK-6482, that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease. The study authors concluded that the drug was well-tolerated with a favorable safety profile.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cancer Research Cell Science Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE